FDA Commissioner Stephen Hahn called the test “groundbreaking” in its efficiency.
― The U.S. Food and Drug Administration on Saturday granted emergency use authorization to Yale School of Public Health’s saliva test to detect COVID-19, after a trial on National Basketball Association players and staff.
SalivaDirect is seen as a cheap, simpler and less invasive testing method that requires no extraction of nucleic acid and can use several readily available reagents.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves COVID-19 saliva test developed at Yale in partnership with the NBA, NBPAA less invasive, saliva-based COVID-19 test developed by Yale researchers in partnership with the NBA and National Basketball Players Association has been approved by the FDA for emergency use.
Weiterlesen »
FDA approves COVID-19 saliva test developed at Yale in partnership with the NBA, NBPAAnne Wyllie, assistant professor and associate research scientist at Yale School of Public Health, said she expects labs to charge about $10 for the SalivaDirect test.
Weiterlesen »
FDA grants emergency use authorization to quick, inexpensive saliva-based Covid-19 diagnostic testThe FDA grants emergency use authorization to a Covid-19 diagnostic test that uses a new, inexpensive method of processing saliva samples. The NBA was among the groups that funded the research.
Weiterlesen »
FDA: Don't use rapid COVID tests on people without symptomsMore sensitive PCR tests should be used on these individuals instead.
Weiterlesen »
FDA authorizes faster, cheaper COVID test in push to pioneer progressThe FDA has granted a new emergency authorization for a saliva test that aims at being cheaper and faster, which could prove to be a breakthrough in fighting coronavirus.
Weiterlesen »